Ligand validation:6D7U

NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose

NAG is a Ligand Of Interest in 6D7U designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6D7U_NAG_B_201	41%	77%	0.173	0.887	0.38	0.53	-	-	0	0	100%	0.9333
6D7U_NAG_C_402	36%	34%	0.132	0.821	0.6	1.95	-	4	0	0	100%	0.9333
6D7U_NAG_F_201	27%	70%	0.174	0.821	0.44	0.71	-	1	0	0	100%	0.9333
6D7U_NAG_D_201	27%	80%	0.213	0.86	0.34	0.5	-	-	0	0	100%	0.9333
6D7U_NAG_C_401	24%	74%	0.201	0.828	0.19	0.81	-	1	0	0	100%	0.9333
6D7U_NAG_A_401	16%	60%	0.251	0.819	0.25	1.27	-	1	0	0	100%	0.9333
6D7U_NAG_E_401	12%	60%	0.259	0.802	0.49	1.03	-	-	5	0	93%	0.9333
6D7U_NAG_A_402	11%	47%	0.233	0.749	0.48	1.52	-	3	0	0	100%	0.9333
6D7U_NAG_E_402	9%	58%	0.221	0.712	0.37	1.2	-	1	0	0	100%	0.9333
4LN3_NAG_K_800	100%	41%	0.04	0.989	0.44	1.83	-	3	0	0	100%	0.9333
4DJ8_NAG_B_201	99%	29%	0.047	0.985	0.6	2.2	-	5	0	0	100%	0.9333
4DJ6_NAG_C_401	99%	47%	0.054	0.984	0.51	1.5	-	3	0	0	100%	0.9333
4LN8_NAG_F_500	98%	17%	0.056	0.975	1	2.58	1	7	1	0	100%	0.9333
4DJ7_NAG_D_201	97%	46%	0.059	0.974	0.53	1.52	-	1	2	0	100%	0.9333
3H0C_NAG_A_794	100%	56%	0.021	0.995	0.61	1.08	-	1	0	0	100%	0.9333
5LDS_NAG_B_1007	100%	67%	0.022	0.995	0.48	0.79	-	-	0	0	100%	0.9333
5O5D_NAG_A_601	100%	65%	0.022	0.994	0.32	0.99	-	1	0	0	100%	0.9333
6MUG_NAG_G_629	100%	76%	0.022	0.994	0.35	0.58	-	-	0	0	100%	0.9333
3GXM_NAG_A_498	100%	45%	0.026	0.992	0.75	1.34	-	2	0	0	100%	0.9333

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.